Clinical characteristics of patients in a case control study of sarcoidosis.

@article{Baughman2001ClinicalCO,
  title={Clinical characteristics of patients in a case control study of sarcoidosis.},
  author={Robert P. Baughman and Alvin S. Teirstein and Marc A. Judson and Milton D. Rossman and Henry Yeager and Eddy A. Bresnitz and Louis R. Depalo and Gary W. Hunninghake and Michael C. Iannuzzi and Carol Johnson Johns and Geoffrey McLennan and David R. Moller and Lee S. Newman and David L. Rabin and Cecile S. Rose and Benjamin A. Rybicki and Steven E. Weinberger and Michael L Terrin and Genell L. Knatterud and Reuben Cherniak},
  journal={American journal of respiratory and critical care medicine},
  year={2001},
  volume={164 10 Pt 1},
  pages={
          1885-9
        }
}
Sarcoidosis may be affected by sex, race, and age. [] Key Method A Case Control Etiologic Study of Sarcoidosis (ACCESS) enrolled 736 patients with sarcoidosis within 6 mo of diagnosis from 10 clinical centers in the United States. Using the ACCESS sarcoidosis assessment system, we determined organ involvement for the whole group and for subgroups differentiated by sex, race, and age (less than 40 yr or 40 yr and older). The study population was heterogeneous in terms of race (53% white, 44% black), sex (64…

Figures and Tables from this paper

The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States.

It is indicated that sarcoidosis tends to improve over time in terms of pulmonary function and medication requirements, and the disease was found to be more severe in blacks than whites.

Clinical characteristics and outcomes of Korean patients with sarcoidosis

The number of diagnosed cases showed an increasing trend, and the mean age at diagnosis was increased compared with that in previous reports, although the prognosis appeared better than that of Westerners.

Clinical features of Sarcoidosis in Oman: A report from the Middle East region.

The clinical picture of the patients with sarcoidosis from Oman was similar to that reported from the rest of the world and region wise, patients were older and arthralgia and hypercalcemia were more common.

SARCOIDOSIS DIAGNOSED IN THE ELDERLY: A CASE CONTROL STUDY.

Erosion and clinical presentation of EOS differs from YOS, including more comorbidities and more uveitis, and Elderly patients are more prone to corticosteroid side-effects.

Sarcoidosis: a single hospital-based study in a 24-year period.

The clinical spectrum of sarcoidosis in Mexican patients differed from other studies, with a higher frequency of cutaneous sarcoIDosis and less pulmonary involvement.

Clinical Characteristics and Organ System Involvement of the University of Minnesota Sarcoidosis Cohort

This cohort features a relatively high frequency of high-risk sarcoidosis phenotypes including cardiac and multiorgan disease and the need for a more reliable biomarker to predict and measure disease severity and outcomes for better clinical management for sarCOidosis patients is presented.

Retrospective study of elderly onset sarcoidosis in Tunisian patients

Young and elderly subjects had common characteristics of sarcoidosis, except for more coexisting chronic morbidities, no erythema nodosum and more frequent high levels of ACE in the elderly group.

Late-Onset Sarcoidosis: A Comparative Study

The 2 groups were similar with regard to oral corticosteroid therapy and immunosuppressive use, although steroid-related adverse events were more common in the elderly group, and Evolution and therapeutic management were not different in the 2 groups.

Analysis of sarcoidosis in the Oporto region (Portugal).

...

References

SHOWING 1-10 OF 48 REFERENCES

Sarcoidosis presenting in patients older than 50 years.

The diagnosis of sarcoidosis should be considered in patients presenting over age 50 with characteristic signs and symptoms including chest radiographic evidence of mediastinal lymphadenopathy, whether diagnosed in young adults or in patients over the age of 50.

Sarcoidosis: epidemiology and prognosis. A 15-year European study.

Patients with Stage I sarcoidosis, i.e., with bilateral hilar adenopathy alone, had the best prognosis, with 50% of the patients showing a normal radiographic picture 15 months after the discovery of the disease.

Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization.

The results should be more generalizable than previous studies done with select populations and should serve as a useful frame of reference for future epidemiologic research of sarcoidosis.

The epidemiology of sarcoidosis in Rochester, Minnesota: a population-based study of incidence and survival.

Survival, compared with that of the North Central United States, was unimpaired in this sarcoidosis incidence cohort.

Epidemiological study on sarcoidosis in Moravia and Silesia.

Standard epidemiological and clinical features of sarcoidosis were evaluated in 24 regional centres from Moravia and Silesia and indicate that improved knowledge of sarCOidosis has brought epidemiological equilibrium to the evaluated area.

HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis.

HLA class II typing is a valuable tool in predicting the outcome of the disease in Scandinavian sarcoidosis patients and enabled a subgrouping into two categories with significantly different clinical courses, even in patients with clinical manifestations normally associated with good prognosis.

"The sarcoidosis map": a joint survey of clinical and immunogenetic findings in two European countries.

The concept that immunogenetic background may at least partly account for the clinical heterogeneity of sarcoidosis is supported, as data obtained in independent studies in two European populations (Italian and Czech) seem to support that.

Course and prognosis of sarcoidosis in a nonreferral setting. Analysis of 86 patients observed for 10 years.

High prevalence of familial sarcoidosis in an Irish population.

The high prevalence of sarcoidosis among siblings reported here (2.4%) suggests that genetic factors significantly predispose to the development of sarCOidosis and that family members of affected patients should be screened for this disease.